Evidence map›Paper›PMID 40241960›Full record

ArticleFrontiers in public health2025

Changes in self-reported physical and mental health, behaviour and economic status among adults by known seropositivity and sociodemographic factors before and after the COVID-19 pandemic outbreak in Ischgl, Austria.

Katie Bates, Wegene Borena, Martin McKee, Lore Hayek, Paul Bouanchaud, Zoltán Bánki, Lydia Riepler, Annika Rössler, Barbara Falkensammer, Jörg Paetzold and 7 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Katie BatesInstitute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.
Wegene BorenaInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Martin McKeeFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Lore HayekDepartment of Political Science, University of Innsbruck, Innsbruck, Austria.
Paul BouanchaudPopulation Services International, London, United Kingdom.
Zoltán BánkiInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Lydia RieplerInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Annika RösslerInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Barbara FalkensammerInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Jörg PaetzoldDepartment of Economics, University of Salzburg, Salzburg, Austria.
Andreas WalserWalser's Surgery, Ischgl, Austria.
Sebastian SchönherrInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Lukas ForerInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
Ludwig KnablInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Janine KimpelInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Dorothee von LaerInstitute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
Hanno UlmerInstitute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In early March 2020, a SARS-CoV-2 outbreak occurred in the ski resort of Ischgl, in Austria. After an initial seroprevalence study in April 2020, a follow-up study in November 2020 showed persistence of high levels of seropositivity. The impacts of SARS-CoV-2 infections and non-pharmaceutical interventions required to reduce transmission were wide-ranging, including worsened mental and physical health and economic damage. Methods: We analysed data from the Ischgl follow-up study. Of the 1,259 adults that participated in the Ischgl-1 study (Ischgl-1), 801 were followed-up. Seropositivity was defined using presence of binding and neutralizing antibodies at Ischgl-1. At follow-up, 7 months later (Ischgl-2), participants reported changes to self-rated mental and physical health, physical activity, alcohol consumption, smoking and economic status. Changes were compared by serological status, using multivariable logistic and multinomial regression models, where appropriate, and adjusting for factors including age, sex, and morbidity. Results: 1 in 2 participants reported experiencing a moderate or severe impact of the pandemic. One fifth of participants reported a worsening in their mental health from November 2019 to November 2020; women and participants aged ≥35 to <70 years were disproportionately affected. Seropositivity was associated with a decline in physical health but no decline in mental health or behaviour changes. Very few participants reported any changes in behaviours. The overriding impact the population of Ischgl was economic-50% of participants reported a worsening of their professional and/or financial situation. Declines in self-reported mental health were associated with the overall experience of the pandemic and economic factors. Conclusion: The population of Ischgl demonstrated a high level of resilience to the pandemic as measured by health. However, certain segments of the population were disproportionately affected, particularly with regard to mental health and economic wellbeing. Future pandemic preparedness must consider how pandemic mitigation strategies can be responsive to context and the wider impacts on mental health and social and economic wellbeing while minimising mortality and safeguarding health systems.

Indexed as

COVID-19Economic StatusHealth StatusMental HealthAdultAgedAustriaFemaleFollow-Up StudiesHumansMaleMiddle AgedPandemicsSARS-CoV-2Self ReportSeroepidemiologic Studiesbehavioureconomic impactsmental healthpandemic (COVID-19)physical healthSARS-CoV-2 infectionself-reported health

Identifiers

PMID40241960
PMCPMC12002084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.